Funder
Tertiary Education Trust Fund
Ahmadu Bello University
Reference45 articles.
1. A tribute to Dr. Gordon Hisashi Sato (December 24, 1927–March 31, 2017);Sato;In Vitro Cell Dev Biol Animal,2018
2. New pyrimidine and pyrazole-based compounds as potential EGFR inhibitors: synthesis, anticancer, antimicrobial evaluation and computational studies;Othman;Bioorg Chem,2021
3. Targeting non-small cell lung cancer with small-molecule EGFR tyrosine kinase inhibitors;Singh;Drug Discov Today,2018
4. 4-Aminoindazolyl-dihydrofuro [3, 4-d] pyrimidines as non-covalent inhibitors of mutant epidermal growth factor receptor tyrosine kinase;Hanan;Bioorg Med Chem Lett,2016
5. Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer;Bistrović;Eur J Med Chem,2018
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Computer-aided discovery of novel SmDHODH inhibitors for schistosomiasis therapy: Ligand-based drug design, molecular docking, molecular dynamic simulations, drug-likeness, and ADMET studies;PLOS Neglected Tropical Diseases;2024-09-12
2. Computational modeling and molecular dynamics studies of methyl sulfonyl acetate derivatives as potent SmTGR inhibitors: insights into binding interactions;Molecular Simulation;2024-09-05
3. Unveiling potent inhibitors for schistosomiasis through ligand-based drug design, molecular docking, molecular dynamics simulations and pharmacokinetics predictions;PLOS ONE;2024-06-26
4. Ligand based-design of potential schistosomiasis inhibitors through QSAR, homology modeling, molecular dynamics, pharmacokinetics, and DFT studies;Journal of Taibah University Medical Sciences;2024-04
5. Mechanistic insights and therapeutic implications of novel pyrazoline derivatives on antioxidant and enzymatic inhibitory activities;Journal of Molecular Structure;2024-01